Copyright: ©Author(s) 2026.
World J Psychiatry. Oct 19, 2026; 16(10): 121714
Published online Oct 19, 2026. doi: 10.5498/wjp.121714
Published online Oct 19, 2026. doi: 10.5498/wjp.121714
Table 1 Comparison of general demographic data between the two groups, mean ± SD/n (%)
| Variable | Fall group (n = 58) | Non-fall group (n = 72) | Statistic | P value |
| Age (years) | 73.58 ± 6.91 | 69.53 ± 6.28 | t = 3.482 | 0.001 |
| Sex | χ2 = 2.341 | 0.126 | ||
| Male | 19 (32.76) | 32 (44.44) | ||
| Female | 39 (67.24) | 40 (55.56) | ||
| Years of education | 8.12 ± 3.41 | 8.73 ± 3.15 | t = 1.067 | 0.288 |
| Marital status | χ2 = 4.523 | 0.033 | ||
| Married | 31 (53.45) | 51 (70.83) | ||
| Widowed/divorced | 27 (46.55) | 21 (29.17) | ||
| Living status | χ2 = 5.872 | 0.015 | ||
| Living with family | 37 (63.79) | 59 (81.94) | ||
| Living alone | 21 (36.21) | 13 (18.06) | ||
| BMI (kg/m2) | 23.28 ± 3.56 | 23.98 ± 3.31 | t = 1.168 | 0.245 |
Table 2 Comparison of clinical data and medication status between the two groups, mean ± SD/n (%)
| Variable | Fall group (n = 58) | Non-fall group (n = 72) | Statistic | P value |
| Duration of osteoporosis (years) | 5.68 ± 3.42 | 4.97 ± 3.18 | t = 1.229 | 0.221 |
| History of falls | 35 (60.34) | 18 (25.00) | χ2 = 16.731 | < 0.001 |
| Number of comorbidities, median (interquartile range) | 4.00 (2.00, 5.00) | 2.00 (1.00, 4.00) | Z = -2.937 | 0.003 |
| Medication | ||||
| Benzodiazepines | 24 (41.38) | 13 (18.06) | χ2 = 8.646 | 0.003 |
| Antidepressants | 8 (13.79) | 5 (6.94) | χ2 = 1.713 | 0.191 |
| Antipsychotics | 3 (5.17) | 2 (2.78) | χ2 = 0.074 | 0.786 |
| Calcium supplementation | 32 (55.17) | 48 (66.67) | χ2 = 1.814 | 0.178 |
| Vitamin D supplementation | 28 (48.28) | 44 (61.11) | χ2 = 2.142 | 0.143 |
| Antihypertensive agents | 41 (70.69) | 43 (59.72) | χ2 = 1.680 | 0.195 |
| Antidiabetic agents | 19 (32.76) | 21 (29.17) | χ2 = 0.196 | 0.658 |
Table 3 Comparison of bone metabolism markers between the two groups, mean ± SD
| Variable | Fall group (n = 58) | Non-fall group (n = 72) | Statistic | P value |
| Blood calcium (mmol/L) | 2.26 ± 0.18 | 2.29 ± 0.16 | 1.007 | 0.316 |
| Serum inorganic phosphorus (mmol/L) | 1.13 ± 0.21 | 1.16 ± 0.19 | 0.861 | 0.391 |
| ALP (U/L) | 89.47 ± 23.68 | 83.92 ± 21.45 | 1.408 | 0.162 |
| 25-hydroxyvitamin D (ng/mL) | 18.36 ± 5.72 | 22.84 ± 6.31 | 4.196 | < 0.001 |
| PTH (pg/mL) | 52.38 ± 18.46 | 47.65 ± 16.92 | 1.531 | 0.128 |
Table 4 Comparison of physical function and cognitive function between the two groups, mean ± SD
| Variable | Fall group (n = 58) | Non-fall group (n = 72) | t value | P value |
| Grip strength (kg) | 21.34 ± 5.86 | 24.78 ± 6.23 | 3.243 | 0.002 |
| TUGT (second) | 15.68 ± 4.73 | 11.94 ± 3.86 | 4.962 | < 0.001 |
| BBS score (points) | 41.53 ± 7.26 | 47.82 ± 6.54 | 5.234 | < 0.001 |
| SPPB score (points) | 8.16 ± 2.34 | 9.73 ± 2.18 | 3.966 | < 0.001 |
| MMSE score (points) | 25.37 ± 3.14 | 26.82 ± 2.86 | 2.773 | 0.006 |
Table 5 Comparison of psychiatric and psychological assessment indicators between the two groups, mean ± SD/n (%)
| Variable | Fall group (n = 58) | Non-fall group (n = 72) | Statistic | P value |
| GDS score (points) | 7.43 ± 3.26 | 4.68 ± 2.85 | t = 5.138 | < 0.001 |
| Positive depressive symptoms | 35 (60.34) | 21 (29.17) | χ2 = 12.746 | < 0.001 |
| GAD-7 score (points) | 6.87 ± 3.52 | 4.21 ± 2.94 | t = 4.691 | < 0.001 |
| Positive anxiety symptoms | 28 (48.28) | 16 (22.22) | χ2 = 9.873 | 0.002 |
| FES-I score (points) | 38.46 ± 9.87 | 27.53 ± 8.64 | t = 6.749 | < 0.001 |
Table 6 Variable assignment table for multivariate logistic regression analysis
| Variable | Assignment | Variable | Assignment |
| Fall (dependent variable) | 0 = no fall, 1 = fall occurred | Grip strength | Continuous variable |
| Age | Continuous variable | TUGT | Continuous variable |
| Marital status | 0 = married, 1 = widowed/divorced | BBS score | Continuous variable |
| Living status | 0 = living with family, 1 = living alone | SPPB score | Continuous variable |
| History of falls | 0 = no, 1 = yes | MMSE score | Continuous variable |
| Number of comorbidities | Continuous variable | GDS score | Continuous variable |
| Benzodiazepine use | 0 = no use, 1 = use | GAD-7 score | Continuous variable |
| 25-hydroxyvitamin D | Continuous variable | FES-I score | Continuous variable |
Table 7 Multivariate logistic regression analysis of fall risk factors in older patients with osteoporosis
| Variable | β | SE | Wald χ2 | OR | 95%CI | P value |
| History of falls | 1.464 | 0.398 | 13.527 | 4.326 | 1.987-9.416 | 0.001 |
| GDS score | 0.294 | 0.089 | 10.912 | 1.342 | 1.127-1.598 | 0.002 |
| GAD-7 score | 0.252 | 0.088 | 8.214 | 1.287 | 1.082-1.531 | 0.005 |
| TUGT | 0.197 | 0.068 | 8.394 | 1.218 | 1.065-1.393 | 0.004 |
| BBS score | -0.115 | 0.038 | 9.136 | 0.891 | 0.826-0.961 | 0.003 |
| 25-hydroxyvitamin D | -0.092 | 0.033 | 7.776 | 0.912 | 0.855-0.973 | 0.006 |
| Constant | -2.867 | 1.724 | 2.767 | 0.057 | 0.096 |
- Citation: Shen D, Sun L, Cheng WP, Wang TT, Gu HY. Construction of a prediction model for fall risk in older patients with osteoporosis and comorbid with psychiatric disorders. World J Psychiatry 2026; 16(10): 121714
- URL: https://www.wjgnet.com/2220-3206/full/v16/i10/121714.htm
- DOI: https://dx.doi.org/10.5498/wjp.121714